Santis Health has been recognized with a 2026 Global Recognition Award for advancing prostate cancer surgery through a clinical model that combines specialized robotic practice, immediate pathological assessment and a sustained focus on functional recovery. The recognition is awarded in Innovation because Santis Health has brought together the Retzius-sparing approach to robotic prostatectomy, the da Vinci Single Port robotic system and intra-operative NeuroSAFE pathology, while using each method to address a defined surgical concern. Its work demonstrates that technical progress has greater value when it is organized around verifiable outcomes, including cancer control, urinary continence and sexual function.

Santis Health operates as a specialist prostate cancer clinic in London and performs nearly 200 operations each year, a caseload that gives its surgical team repeated experience with complex clinical decisions. The clinic’s approach reflects the reality that radical prostatectomy requires surgeons to remove disease thoroughly, yet it also requires them to protect critical structures whenever the cancer and the patient’s circumstances permit. Its published results and record of presenting clinical findings at international scientific meetings show a willingness to place performance before professional scrutiny, while its multidisciplinary process ensures that treatment planning does not rest on surgical judgment alone.

Integrated Surgical Methods

The Retzius-sparing technique preserves anatomy at the front of the prostate when appropriate, and this can support earlier recovery of urinary continence after surgery. Santis Health applies the technique within a robotic procedure, so surgeons can work with magnified visualization and controlled movements while they navigate anatomy that is closely connected to post-operative function. The method does not remove the need for sound surgical judgment, but it gives the team a structured way to pursue cancer removal without treating continence as an afterthought.

The da Vinci Single Port robotic system adds another element to Santis Health’s surgical practice because it supports minimally invasive access through a single-port platform and allows the clinical team to tailor the operation to the patient’s needs. Technology alone cannot establish superior care, yet Santis Health has paired this system with a surgical team that has worked together for 15 years and has built familiarity through a high volume of related procedures. That continuity matters because surgical outcomes depend on coordinated decisions before, during and after an operation, while each member of the care team must understand both the clinical plan and the consequences of changing it.

Pathology And Clinical Accountability

Intra-operative NeuroSAFE pathology distinguishes Santis Health’s approach because it allows tissue assessment during the operation rather than requiring all findings to be considered only after surgery has concluded. Surgeons can use that information to assess cancer margins while they decide whether nerve tissue can be preserved, and the process addresses the tension between complete cancer removal and the protection of sexual function. This model makes pathology an active part of surgical decision-making, which gives the team additional evidence at a moment when the opportunity to adjust the procedure remains available.

Multidisciplinary review provides another layer of accountability, since specialists in urology, oncology, pathology, radiology and nuclear medicine consider imaging and treatment plans before a patient moves forward. Santis Health’s process includes review from experienced consultants, and that structure connects diagnosis, treatment planning and surgical delivery rather than dividing them into separate stages with limited communication. The Rasch model used in the final assessment created a linear measurement scale across the award criteria, allowing the panel to compare Santis Health’s achievements in innovation, leadership, service and clinical impact precisely with those of other shortlisted recipients.

Final Words

Santis Health has earned a 2026 Global Recognition Award because it has made innovation a practical part of clinical care, and it has linked advanced surgical methods to outcomes that matter to patients after treatment. Its model combines robotic surgery, anatomical preservation, intra-operative pathology, multidisciplinary planning and outcomes reporting, while it maintains a clear focus on both disease management and life after surgery. The clinic’s work shows that progress in prostate cancer care requires more than technical capacity, because it also requires reliable systems for applying that capacity with care and accountability.

High surgical volume, a long-standing clinical team and a record of published results give Santis Health a basis for recognition that extends beyond the use of any single surgical device or technique. “Santis Health demonstrates exceptional qualities through its ability to connect advanced surgical methods with careful clinical judgment, measurable outcomes and a sustained commitment to the needs of patients,” said Alex Sterling, a spokesperson for Global Recognition Awards. Its selection in Innovation recognizes a disciplined contribution to prostate cancer treatment, where cancer control and the preservation of function are treated as connected responsibilities rather than competing goals.